ニュース

VIVEbiotech has published a scientific paper in the journal Viruses

VIVEbiotech has participated in a second roundtable in Pharma’s Almanac entitled “How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?”.

Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, has contributed to a Pharma’s Almanac’s roundtable discussing how technological advancements are reshaping the roles and capabilities of CDMOs and CROs.

Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, answered some questions for The Medicine Maker around the trends and key topics that were covered throughout American Society of Gene & Cell Therapy´s (ASGCT) annual meeting that took place last May in Baltimore.

Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, participates in a roundtable article by Pharma’s Almanac.

The MAGIC Consortium is proud to announce the participation of Instituto de Medicina Molecular João Lobo Antunes (iMM) in the MAGIC Project.

VIVEbiotech has been awarded the prize “New Company of Gipuzkoa 2024” by ADEGI, Association of Companies of Gipuzkoa.

Natalia Elizalde, Chief Business Development Officer of VIVEbiotech, was interviewed by IBTV during the ASGCT´s annual meeting that took place three weeks ago in Baltimore.

Juan Camilo Estrada, Head of Analytical Development at VIVEbiotech, will be presenting at the upcoming SLAS Europe 2024 Conference & Exhibition.

VIVEbiotech is participating at the American Society of Gene & Cell Therapy´s (ASGCT) Annual Meeting at the Baltimore Convention Center.